Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-21

Clinical Trial Update: Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation [Phase 4]

View source ↗

Summary

Phase 4 trial update on very high power ablation in patients with atrial fibrillation undergoing first pulmonary vein isolation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AZ Sint-Jan AV | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED